The RING domain of Mdm2 can inhibit cell proliferation

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1222-1230

  Dang, Jinjun ^a   Kuo, Mei Ling ^a   Eisehen, Christine M ^a   Stepanova, Lilia ^a   Sherr, Charles J ^a   Roussel, Martine F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; ISOPROTEIN; PHOSPHOPROTEIN; PROTEIN MDM2; PROTEIN P53; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; ONCOGENE MYC; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; ANIMALS; CELL DIVISION; GROWTH INHIBITORS; LYMPHOMA; MICE; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 0036168984     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line
2. The MDM2 gene amplification database
3. Mdm2: The ups and downs
4. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
5. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth
6. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
7. Rescue of embryonic lethality in Mdm-2-deficient mice by absence of p53
8. Centrosome hyperamplification in human cancer: Chromosome instability induced by p53 mutation and/or Mdm2 overexpression
9. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
10. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
11. Mapping of the p53 and mdm-2 interaction domains
12. MDM2 inhibits p300-mediated p53 acetytation and activation by forming a ternary complex with the two proteins
13. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
14. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
15. ARF with Mdm2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53
16. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase
17. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
18. Nucleolar Arf sequesters Mdm2 and activates p53
19. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function
20. Human Mdm2 mediates multiple monoubiquitination of p53 by a mechanism requiring enzyme isomerization
21. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
22. The MDM2 RING-finger domain is required to promote p53 nuclear export
23. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking
24. The p53-mdm-2 autoregulatory feedback loop
25. ARF
26. ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage
27. Tumor surveillance via the ARF-p53 pathway
28. The ARF/p53 pathway
29. Control of p53 ubiquitination and nuclear export by MDM2 and ARF
30. MDM2-master regulator of the p53 tumor suppressor protein
31. MDM2: Life without p53
32. MDMX: A novel p53-binding protein with some functional properties of MDM2
33. Comparative study of the p53-mdm2 and p53-MDMX interfaces
34. Hdmx stabilizes Mdm2 and p53
35. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms
36. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53
37. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
38. H Analysis of the degradation function of Mdm2
39. MdmX protects p53 from Mdm2-mediated degradation
40. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain
41. Identification and characterization of multiple mdm-2 protein and mdm-2-p53 protein complexes
42. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer
43. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms
44. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells
45. An alternatively spliced HDM 2 product increases p53 activity by inhibiting HDM2
46. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma
47. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer
48. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas
49. Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement
50. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
51. Rescue of defective mitogenic signaling by D-type cyclins
52. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo
53. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
54. Ink4α loss on senescence of murine bone marrow-derived pre-B cells and macrophages
55. Alternative reading frames of the INK4α tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
56. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product
57. Cooperative signals governing ARF-Mdm2 interaction and nucleolar localization of the complex
58. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex
59. MDM2 to destabilize p53
60. The human oncoprotein MDM2 arrests the cell cycle: Elimination of its cell-cycle-inhibitory function induces tumorigenesis
61. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
62. ARF, participates in a regulatory feedback loop with p53 and MDM2
63. Identification of a cryptic nucleolar-localization signal in MDM2
64. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases
65. MDM2 interacts with MDMX through their RING finger domains
66. 1 arrest that is suppressed by MDM2
67. INK4α